These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25052473)

  • 1. Estrogen and its role in thyroid cancer.
    Derwahl M; Nicula D
    Endocr Relat Cancer; 2014 Oct; 21(5):T273-83. PubMed ID: 25052473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause.
    Rubio GA; Catanuto P; Glassberg MK; Lew JI; Elliot SJ
    Surgery; 2018 Jan; 163(1):143-149. PubMed ID: 29128169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen action on thyroid progenitor cells: relevant for the pathogenesis of thyroid nodules?
    Xu S; Chen G; Peng W; Renko K; Derwahl M
    J Endocrinol; 2013 Jul; 218(1):125-33. PubMed ID: 23645248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma.
    Rocha AS; Risberg B; Magalhães J; Trovisco V; de Castro IV; Lazarovici P; Soares P; Davidson B; Sobrinho-Simões M
    Hum Pathol; 2006 May; 37(5):562-8. PubMed ID: 16647954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
    Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
    Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
    Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
    Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual dimorphism and thyroid dysfunction: a matter of oxidative stress?
    Fortunato RS; Ferreira AC; Hecht F; Dupuy C; Carvalho DP
    J Endocrinol; 2014 May; 221(2):R31-40. PubMed ID: 24578296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mitogen-activated protein kinase (MAPK) signaling pathway in papillary thyroid cancer. From the molecular bases to clinical practice].
    Zafon C; Obiols G
    Endocrinol Nutr; 2009 Apr; 56(4):176-86. PubMed ID: 19627734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of oestrogen receptors in 351 human thyroid glands.
    Tavangar SM; Monajemzadeh M; Larijani B; Haghpanah V
    Singapore Med J; 2007 Aug; 48(8):744-7. PubMed ID: 17657383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is gender difference in postnatal thyroid growth associated with specific expression patterns of androgen and estrogen receptors?
    Stanley JA; Aruldhas MM; Yuvaraju PB; Banu SK; Anbalagan J; Neelamohan R; Annapoorna K; Jayaraman G
    Steroids; 2010 Dec; 75(13-14):1058-66. PubMed ID: 20670640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females.
    Antico-Arciuch VG; Dima M; Liao XH; Refetoff S; Di Cristofano A
    Oncogene; 2010 Oct; 29(42):5678-86. PubMed ID: 20676139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer.
    Chen GG; Vlantis AC; Zeng Q; van Hasselt CA
    Curr Cancer Drug Targets; 2008 Aug; 8(5):367-77. PubMed ID: 18690843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
    Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
    Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
    Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.
    Hamatani K; Eguchi H; Ito R; Mukai M; Takahashi K; Taga M; Imai K; Cologne J; Soda M; Arihiro K; Fujihara M; Abe K; Hayashi T; Nakashima M; Sekine I; Yasui W; Hayashi Y; Nakachi K
    Cancer Res; 2008 Sep; 68(17):7176-82. PubMed ID: 18757433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions.
    Lewy-Trenda I
    Pol J Pathol; 2002; 53(2):67-72. PubMed ID: 12140869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.